Health care stocks were mixed premarket Thursday, with The Health Care Select Sector SPDR Fund (XLV) marginally higher and the iShares Biotechnology ETF (IBB) down 0.4%.
Nano-X Imaging (NNOX) shares were up past 15% after the company said it received 510(k) clearance from the US Food and Drug Administration for its Nanox.ARC stationary X-ray system.
Patterson Companies (PDCO) stock was over 7% higher after the company posted an increase in its fiscal Q2 net sales.
Mesoblast (MESO) shares were down more than 4% even after the company said the US Food and Drug Administration granted the company's second-generation cell therapy, Revascor, a regenerative medicine advanced therapy designation.
Comments